Dyadic International, Inc. (DYAI)
NASDAQ: DYAI · Real-Time Price · USD
0.850
+0.040 (4.93%)
Apr 29, 2026, 9:30 AM EDT - Market open
Dyadic International Market Cap
Dyadic International has a market cap or net worth of $30.97 million as of April 29, 2026. Its market cap has decreased by -14.20% in one year.
Market Cap
30.97M
Enterprise Value
27.26M
1-Year Change
-14.20%
Ranking
Category
Stock Price
$0.85
Market Cap Chart
Since April 18, 2019, Dyadic International's market cap has decreased from $94.80M to $30.97M, a decrease of -67.33%. That is a compound annual growth rate of -14.71%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 27, 2026 | 29.90M | -12.06% |
| Dec 31, 2025 | 34.00M | -34.36% |
| Dec 31, 2024 | 51.80M | 11.64% |
| Dec 29, 2023 | 46.40M | 32.19% |
| Dec 30, 2022 | 35.10M | -72.34% |
| Dec 31, 2021 | 126.90M | -14.20% |
| Dec 31, 2020 | 147.90M | 4.89% |
| Dec 31, 2019 | 141.00M | 48.73% |
View and export this data all the way back to 2019.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Senti Biosciences | 33.95M |
| Pluri | 33.62M |
| Evaxion | 33.61M |
| Boundless Bio | 33.61M |
| IGC Pharma | 33.31M |
| Outlook Therapeutics | 32.96M |
| Celularity | 32.01M |
| Tevogen Bio Holdings | 31.44M |